Orexo (C5G.F) Stock Highlights

1.15 | +0.88%

2024-10-21 05:33:34

Orexo AB develops pharmaceuticals and digital therapies addressing unmet needs within the space of substance use disorders and mental health. The products are commercialized by Orexo in the USA or via partners worldwide. The main market is the American market for buprenorphine/naloxone products, where the company commercializes its product Zubsolv for treatment of opioid use disorder. The head office, where research and development is also performed, is situated in Uppsala, Sweden.

Statistics

Range Today

1.15 1.15

Volume Today 0

Range 1 Year

1.14 2.02

Volume 1 Year 7.52K

Range 3 Year

0.7 3.76

Volume 3 Year 23.2K

Range 10 Year

0.7 8.164

Volume 10 Year 67.12K

Highlights

Market Capitalization 45.19M (micro)

Floating Shares 21.14M

Current Price 1.15

Price To Earnings -4.59

Price To Revenue 0.62

Price To Book 1.64

Earnings Per Share -0.25

Payout Ratio 0%

Performance

Latest +0.88%

1 Month -8%

3 Months -19.01%

6 Months -20.69%

1 Year -12.21%

3 Years -65.98%

5 Years -76.95%

10 Years -80.36%

Benchmarks

Market Capitalization

0 / 54

Gross Profits

0 / 39

Total Revenue

0 / 50

Total Rank

0 / 54

Free Cashflow

0 / 54

Performance 5 years

0 / 54

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.